Peer Review reports
From: Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes
Original Submission | ||
---|---|---|
28 May 2018 | Submitted | Original manuscript |
14 Jun 2018 | Author responded | Author comments - Patricia McLaughlin |
Resubmission - Version 2 | ||
14 Jun 2018 | Submitted | Manuscript version 2 |
9 Sep 2018 | Reviewed | Reviewer Report - Alvin Munsamy |
17 Sep 2018 | Reviewed | Reviewer Report - Sarah Atkinson |
23 Oct 2018 | Author responded | Author comments - Patricia McLaughlin |
Resubmission - Version 3 | ||
23 Oct 2018 | Submitted | Manuscript version 3 |
1 Dec 2018 | Reviewed | Reviewer Report - Sarah Atkinson |
14 Dec 2018 | Reviewed | Reviewer Report - Alvin Munsamy |
8 Jan 2019 | Author responded | Author comments - Patricia McLaughlin |
Resubmission - Version 4 | ||
8 Jan 2019 | Submitted | Manuscript version 4 |
17 Jan 2019 | Author responded | Author comments - Patricia McLaughlin |
Resubmission - Version 5 | ||
17 Jan 2019 | Submitted | Manuscript version 5 |
Publishing | ||
18 Jan 2019 | Editorially accepted | |
28 Jan 2019 | Article published | 10.1186/s12886-019-1044-y |
You can find further information about peer review here.